Clinical Guides
Myasthenia Gravis
A clinically focused guide to diagnosing autoimmune myasthenia gravis, recognising bulbar and respiratory crisis, using antibody and neurophysiology tests, and coordinating symptomatic treatment, immunotherapy, thymus assessment and pregnancy care in India.
MedNext Academy | 14 min read
Myasthenia Gravis
A clinically focused guide to diagnosing autoimmune myasthenia gravis, recognising bulbar and respiratory crisis, using antibody and neurophysiology tests, and coordinating symptomatic treatment, immunotherapy, thymus assessment and pregnancy care in India.
Summary
Myasthenia gravis (MG) is an autoimmune disorder of neuromuscular transmission causing fluctuating, fatigable weakness. Ptosis and diplopia are common, but facial, bulbar, neck, limb and respiratory muscles may be affected. Sensation, pupils and tendon reflexes are generally preserved. Symptoms vary across the day and with exertion, infection, heat, surgery, pregnancy or medicines, yet brief rest-related improvement is neither required nor diagnostic. Autoantibodies most often target the acetylcholine receptor; muscle-specific kinase, LRP4 and seronegative phenotypes require specialist interpretation.
Myasthenic crisis is respiratory failure or severe airway compromise from myasthenic weakness requiring ventilatory support. Impending crisis can present with deteriorating speech, swallowing, cough, neck flexion or ventilation before oxygen saturation falls. Such patients need monitored hospital care, repeated respiratory and bulbar assessment, trigger treatment and early airway planning. Intravenous immunoglobulin or plasma exchange provides short-term immunomodulation in crisis or significant exacerbation. Pyridostigmine is symptomatic therapy; corticosteroids and steroid-sparing immunosuppressants are used for disease control but can initially worsen weakness and require monitoring.
All confirmed MG should prompt chest imaging for thymoma. Thymoma generally requires oncological and thoracic-surgical evaluation. Thymectomy also has evidence in selected adults with acetylcholine-receptor-antibody-positive generalised non-thymomatous MG, but it is elective and not a rescue procedure during unstable crisis. Pregnancy needs preconception planning because some immunosuppressants are teratogenic, disease course is unpredictable and neonatal transient weakness can occur. Management must be individualised by a neuromuscular specialist; this guide does not authorise unsupervised dose changes or promise that expensive biologic treatment is superior for every patient.
How Common Is It?
MG is uncommon but increasingly recognised across age groups. The 2016 international consensus guidance cited incidence estimates of approximately 0.3 to 2.8 per 100,000, while prevalence varies by population, ascertainment and survival. These are international literature estimates, not a current national Indian census. Modern antibody testing, neurophysiology, ageing populations and improved survival increase detected prevalence, so older numbers should not be presented as a fixed contemporary burden. Referral-centre cohorts over-represent refractory disease, thymoma, crisis and patients able to access specialised testing.
Age and sex patterns are useful but not diagnostic. Younger-onset disease is often described more frequently in women and later-onset disease in men, while ocular-only and generalised patterns occur in both. Children can develop juvenile MG. Thymoma-associated MG forms a clinically important minority. MuSK-antibody disease may show prominent facial, bulbar, neck or respiratory weakness, whereas acetylcholine-receptor-antibody disease spans ocular and generalised phenotypes. These associations overlap and cannot replace antibody testing and clinical localisation.
India lacks one universally representative registry capable of supplying a precise nationwide incidence or prevalence for this guide. Case recognition is affected by distance to neurology, cost of antibodies and single-fibre electromyography, availability of refrigerated or monitored therapies and confusion with brainstem, motor-neurone, muscle or functional disorders. The practical burden is disproportionate to frequency because crisis consumes ICU resources and chronic disease needs repeated review, laboratory monitoring and reproductive counselling. Local services should audit diagnostic delay, crisis admission, thymus imaging, treatment toxicity and patient-reported function rather than claim market-style totals. Rare disease status should accelerate referral for a compatible syndrome, not lower suspicion.
Risk Factors
MG is autoimmune rather than a disorder acquired through lifestyle. Personal or family autoimmune disease, including autoimmune thyroid disease, can coexist and supports broader clinical context without confirming MG. Thymic hyperplasia and thymoma are associated with acetylcholine-receptor-antibody MG, which is why chest imaging is part of assessment. Immune checkpoint inhibitors can cause a rapidly severe MG phenotype, sometimes overlapping with myositis and myocarditis; recent cancer immunotherapy must therefore be asked about explicitly and escalated urgently. A history of another autoimmune illness or cancer changes testing and safety planning but is not a bedside diagnostic criterion.
Physiological stress can expose or worsen weakness. Common precipitants of exacerbation or crisis include respiratory or other infection, surgery, aspiration, pregnancy or postpartum change, sleep deprivation, heat, and reduction or interruption of effective treatment. Thyroid dysfunction and electrolyte disturbance can aggravate symptoms. Medication triggers include aminoglycoside, fluoroquinolone and macrolide antibiotics, magnesium, beta-blockers, selected antiarrhythmics, neuromuscular-blocking agents and immune therapies. The association and risk differ by drug and patient; necessary treatment should be reviewed rather than reflexively withheld.
Pregnancy does not have a predictable effect: MG may improve, remain stable or worsen, including postpartum. Maternal antibodies can cause transient neonatal MG. Arthrogryposis from fetal akinesia is rare but important in counselling. Risk assessment also includes aspiration, obesity, lung disease and limited ventilatory reserve, which magnify crisis consequences. In India, fragmented prescribing is an avoidable systems risk: antibiotics, magnesium-containing preparations, sedatives or anaesthetic drugs may be given without the MG diagnosis being visible. Patients should carry a medicine list and emergency information. None of these factors distinguishes MG from botulism, Lambert-Eaton syndrome, thyroid eye disease or a cranial-nerve lesion.
Diagnosis
History
Define the weak muscles, fluctuation and functional consequences. Ask about drooping eyelids, intermittent double vision, difficulty sustaining upgaze, smiling, chewing, keeping the jaw closed, swallowing liquids or solids, nasal or fading speech, head drop, arm elevation, stair climbing and breathlessness. Establish whether weakness worsens over minutes of activity and improves with rest, but recognise variable patterns. Ask about choking, weight loss, recurrent chest infection, morning headache, orthopnoea and inability to lie flat. Record onset, progression, prior crisis, autoimmune disease, thymic symptoms, pregnancy plans, infection, surgery and every prescription, over-the-counter and traditional medicine.
Examination
Observe ptosis, ocular alignment and extraocular movements, then use safe sustained effort to demonstrate fatigability without exhausting a vulnerable patient. Test facial closure, cheek inflation, palate, voice, tongue, jaw and neck flexion, and document proximal and distal limb power. Sensation, pupils, coordination and reflexes should be assessed to identify mimics. Evaluate cough, secretion handling and swallowing before oral intake if bulbar symptoms are significant. In possible crisis, repeat forced vital capacity and inspiratory pressure where feasible, respiratory rate, speech and neck strength; oxygen saturation alone is inadequate.
Investigations
Test acetylcholine-receptor antibodies first in an appropriate phenotype, followed by MuSK and selected LRP4 or cell-based assays when suspicion persists. A negative panel does not exclude MG. Repetitive nerve stimulation demonstrates a decrement, while single-fibre electromyography is more sensitive but not specific and depends on muscle selection and expertise. Ice-pack testing can support ptosis assessment but is not definitive. Chest CT or MRI evaluates thymoma in confirmed disease. Check thyroid function and phenotype-led alternatives. Brain or orbital imaging is used for focal ocular or central mimics. Bedside edrophonium testing is now rarely appropriate because of cardiac and cholinergic risk. Diagnosis combines clinical pattern, antibodies, neurophysiology and treatment response under specialist judgement.
Differential Diagnosis
Lambert-Eaton myasthenic syndrome usually causes proximal leg weakness, autonomic symptoms and reduced reflexes that may facilitate after exercise; ocular and bulbar symptoms can occur, and small-cell lung cancer must be considered. Botulism causes acute descending paralysis with pupillary and autonomic involvement and may follow contaminated food, a wound or injection. Neurotoxic snakebite can produce ptosis, ophthalmoplegia, bulbar weakness and respiratory failure after an exposure that may initially be overlooked. Organophosphate poisoning adds muscarinic features. These are emergencies and should not await an MG antibody result.
Brainstem stroke, multiple sclerosis, cranial-nerve palsy, aneurysm and intracranial or orbital mass can cause diplopia or bulbar findings, often with fixed anatomical patterns, sensory signs, ataxia or pupil involvement. Thyroid eye disease produces restrictive rather than fatigable ophthalmoplegia and may show lid retraction or proptosis. Horner syndrome, levator dehiscence and chronic progressive external ophthalmoplegia enter a ptosis differential. Motor-neurone disease can cause bulbar and limb weakness with denervation and upper-motor-neurone signs; sensation is also preserved, so reflex and tongue findings matter.
Inflammatory, endocrine, metabolic, mitochondrial and drug-induced myopathies often cause proximal weakness and may raise creatine kinase. Immune checkpoint inhibitor toxicity can overlap MG with myositis and myocarditis, demanding troponin, ECG and muscle assessment rather than a narrow MG label. Guillain-Barré syndrome typically has areflexia and sensory symptoms, although variants can overlap. Fatigue from anaemia, sleep disorder, depression or systemic illness is not the same as demonstrable fatigable weakness. Functional neurological disorder requires positive internal inconsistency, not negative antibody tests alone. Cholinergic excess from too much acetylcholinesterase inhibitor may worsen secretions, fasciculation, diarrhoea and weakness; clinical assessment, not an unsupervised drug challenge, separates it from myasthenic worsening.
Management
Set individual treatment goals: minimal or no function-limiting weakness with acceptable adverse effects. Pyridostigmine often provides first-line symptomatic benefit, particularly in acetylcholine-receptor-antibody disease, but does not alter the autoimmune process. Persistent generalised or troublesome ocular weakness usually prompts immunotherapy. Corticosteroids are effective but may transiently worsen weakness when started or escalated, especially with bulbar or respiratory involvement; high-risk initiation belongs in a monitored plan. Azathioprine, mycophenolate, tacrolimus, ciclosporin, methotrexate, rituximab, complement inhibitors and neonatal-Fc-receptor blockers occupy different evidence, antibody, safety, cost and regulatory niches. No algorithm makes a high-cost agent the universal next step.
Impending or established crisis requires ICU or high-dependency care, trigger treatment, frequent swallowing and ventilatory assessment and early anaesthetic involvement. Elective intubation is preferable to an arrest airway. IVIG and plasma exchange are short-term therapies; plasma exchange may act faster in some severe settings, while access, haemodynamic stability, sepsis, venous access and product supply influence choice. Cholinesterase inhibitor handling during intubated crisis is individualised because excessive secretions complicate ventilation. Treat infection and aspiration, prevent thrombosis and pressure injury, supply nutrition and begin rehabilitation without fatiguing muscle.
Image the thymus in confirmed MG. Resect thymoma when oncologically appropriate. The MGTX trial supports thymectomy plus prednisone in selected adults aged 18 to 65 with acetylcholine-receptor-antibody-positive generalised non-thymomatous MG of under five years' duration, improving clinical scores and reducing prednisone exposure over three years. It does not prove benefit for every age, antibody or ocular phenotype. Thymectomy is elective after stabilisation. Review response with reproducible measures such as MG-ADL and clinical examination, taper treatment cautiously, vaccinate and screen for infection where immunotherapy requires it, and maintain an emergency relapse plan.
Prescribing Information
Pyridostigmine dose and interval are titrated to function and adverse effects, not copied from a generic schedule. Abdominal cramps, diarrhoea, sweating, salivation, bronchial secretion, bradycardia and fasciculation suggest cholinergic burden. Renal impairment may prolong effect. MuSK-antibody disease can respond poorly or develop troublesome cholinergic effects. Excess dosing does not overcome a crisis and can worsen secretion management. Sustained-release preparations have variable roles. Patients should not repeatedly self-escalate for fatigue without confirming that the symptom is myasthenic weakness.
Corticosteroids can cause early worsening as well as infection, hyperglycaemia, hypertension, mood change, osteoporosis, cataract and adrenal suppression. Start and taper under a specialist plan with risk-appropriate bone, glucose, blood-pressure, eye and infection care. Azathioprine requires blood-count and liver monitoring and consideration of thiopurine methyltransferase or NUDT15-related toxicity according to local practice. Mycophenolate and methotrexate are teratogenic and require reliable contraception and preconception withdrawal planning; mycophenolate should not be used during pregnancy. Some medicines have a delayed benefit, so bridge and taper decisions require patience rather than rapid stacking.
IVIG carries infusion, thrombosis, haemolysis and renal risks; plasma exchange carries vascular-access, hypotension, electrolyte, bleeding and infection risks. Complement inhibitors require meningococcal risk mitigation under product and national guidance, yet vaccination does not remove all infection risk. Rituximab needs infection and hepatitis screening and is particularly considered in inadequately controlled MuSK-antibody MG; its efficacy in refractory acetylcholine-receptor-antibody MG is less certain in the 2020 consensus. Review antibiotics, beta-blockers, magnesium, antiarrhythmics, sedatives and anaesthetic neuromuscular blockers. Drug-caution lists guide monitoring; they are not substitutes for treating life-threatening infection or cardiac disease with informed specialist oversight.
When to Refer
Refer suspected MG promptly to neurology, ideally a clinician experienced in neuromuscular disease. Provide the distribution and fatigability of weakness, swallowing and respiratory features, medicine and infection history, examination, antibody tests already sent and any imaging. New isolated ptosis or diplopia still needs examination for pupil abnormalities, pain, fixed cranial-nerve patterns and central signs that may require urgent imaging. Confirmed ocular MG needs follow-up because generalisation can occur and persistent disabling symptoms may justify immunotherapy. Chest imaging for thymoma and shared treatment ownership should not be lost between diagnostic and follow-up visits.
Arrange same-day emergency assessment for worsening dysphagia, choking, nasal or fading speech, weak cough, secretion difficulty, head drop, orthopnoea, rapid shallow breathing or declining respiratory measurements. Call critical care and anaesthesia early when crisis is possible. Do not transfer an unstable patient to a distant centre without airway capability and monitoring. Possible immune-checkpoint-inhibitor MG, especially with myalgia, raised troponin, cardiac symptoms or creatine-kinase elevation, needs urgent oncology, neurology and cardiology coordination because overlap myocarditis or myositis can be fatal.
Refer every thymoma to an experienced thoracic oncology and surgical pathway; elective non-thymomatous thymectomy decisions also need neurologist and surgeon review after stabilisation. Pregnancy planning should involve neurology and a high-risk obstetric team before conception where possible, with neonatal services informed near delivery. Surgery of any kind requires anaesthetic planning because sensitivity to neuromuscular blockers and postoperative respiratory weakness varies. In India, referral must account for antibody, neurophysiology, ICU, apheresis and drug availability. A named receiving clinician, transport plan and explicit crisis precautions are more valuable than an unprioritised letter.
Red Flags
The critical red flags are loss of airway protection and ventilatory reserve: repeated choking, inability to swallow saliva, pooling secretions, a weak cough, whispering or fading speech, inability to count through a breath, head drop, orthopnoea, paradoxical breathing, rapid shallow respiration, falling forced vital capacity or inspiratory pressure, exhaustion and rising carbon dioxide. Oxygen saturation may remain normal until late. Bulbar weakness can obstruct the upper airway even when a spirometry value appears less alarming. Stop oral intake if swallowing is unsafe, monitor frequently and plan intubation before emergency collapse.
Abrupt focal neurological deficit, severe headache, altered consciousness, pupil involvement, ataxia or a fixed cranial-nerve pattern suggests stroke, aneurysm, brainstem or orbital disease rather than routine MG. Fever, diarrhoea, wound or food exposure, envenomation possibility, autonomic signs or descending paralysis raises botulism, toxin or snakebite. Reduced reflexes and sensory symptoms suggest a neuropathy. Marked muscle pain, dark urine, elevated creatine kinase, chest pain, arrhythmia or troponin elevation after immune checkpoint therapy signals myositis or myocarditis overlap and requires emergency multispecialty care.
Treatment red flags include worsening soon after corticosteroid initiation, excessive bronchial or oral secretions with diarrhoea and fasciculation on pyridostigmine, sepsis during immunosuppression, thrombosis or renal injury after IVIG, and catheter complication during plasma exchange. New weakness after magnesium, an aminoglycoside, fluoroquinolone, macrolide, beta-blocker, antiarrhythmic or anaesthetic exposure requires medicine reconciliation, but essential drugs are not stopped blindly. Pregnancy with declining bulbar or respiratory function is an obstetric and neurological emergency. Any rapid deterioration after missed medication needs assessment of both disease activity and the reason access failed.
Indian Clinical Context
MG care in India spans neurology clinics with comprehensive antibody panels and ICUs capable of plasma exchange to districts where only acetylcholine-receptor antibodies or repetitive stimulation are accessible. A safe system does not make single-fibre electromyography or every antibody a prerequisite for referral. Document a convincing phenotype, exclude immediate mimics and protect swallowing and breathing while arranging specialist confirmation. Where spirometry is unavailable, serial speech, cough, neck strength, respiratory pattern and secretion handling remain useful but do not eliminate the need for transfer. Families should be told that a normal saturation is not reassurance against ventilatory failure.
Pyridostigmine and older immunosuppressants are more accessible than biologics, but affordability does not remove the need for blood counts, liver tests, infection screening, contraception and toxicity review. IVIG cost and supply can delay crisis treatment; plasma exchange may be available only at tertiary centres and requires safe transport before respiratory collapse. Public funding, hospital social work and manufacturer assistance should be explored without overstating eligibility. Biologic promotion is particularly hazardous: antibody status, prior therapy, infection risk, vaccination, licensing and total ongoing cost all matter, and the evidence base differs across subgroups.
Tuberculosis, hepatitis and endemic infection risks shape immunosuppression screening, while unregulated combinations and over-the-counter magnesium or antibiotics complicate prescribing. Patients should carry a bilingual diagnosis and caution card, but a long prohibited-drug list can cause undertreatment of infection; emergency clinicians need risk-ranked advice and neurology consultation. Thymoma surgery should be concentrated in appropriately equipped teams. Pregnancy planning needs early substitution of teratogenic drugs, not abrupt cessation after conception. Shared records across neurology, obstetrics, oncology, anaesthesia and primary care reduce preventable crisis in a fragmented system.
NMC Competency Mapping
NMC physiology competency PY3.4 addresses the structure and function of the neuromuscular junction and mechanism of transmission. PY3.5 explicitly includes applied neuromuscular-junction disorders such as myasthenia gravis, Lambert-Eaton syndrome and neuromuscular-blocking agents. These competencies support explaining how reduced safety factor produces fatigable weakness, how presynaptic and postsynaptic disorders differ, and why medicines that impair transmission can worsen disease. Pharmacology teaching links acetylcholinesterase inhibition, immunotherapy adverse effects and anaesthetic neuromuscular blockade to bedside safety.
Clinical learning outcomes include eliciting ocular, bulbar, limb and respiratory fatigability; examining pupils, reflexes, sensation, cranial muscles and proximal strength; and distinguishing central, peripheral nerve, muscle and neuromuscular-junction patterns. Learners should interpret acetylcholine-receptor and MuSK antibodies, repetitive stimulation, single-fibre electromyography and chest imaging without treating any result as infallible. They must recognise impending crisis, assess swallowing and ventilation, reconcile precipitating medicines and summon critical-care support. Management knowledge includes pyridostigmine's symptomatic role, delayed immunosuppressive benefit, short-term IVIG or exchange, thymoma evaluation and pregnancy precautions.
Assessment should use staged cases rather than isolated recall. An ocular presentation can evolve into dysphagia and a falling vital capacity, testing whether the learner changes urgency. A later station can ask which drug exposure may worsen transmission or which thymectomy evidence applies. Examiners should reward caveats: negative antibodies do not exclude MG; normal saturation does not exclude crisis; MGTX applies to a defined acetylcholine-receptor-positive generalised population; teratogenic drugs need preconception planning. Undergraduate competence is recognition, initial safety and supervised management—not independent initiation of immunosuppression, apheresis, biologics or anaesthesia. The curriculum defines educational achievement, not a prescribing licence.
Key Exam Pearls for NEET PG
Think of MG when fluctuating ptosis, diplopia, dysarthria, dysphagia or proximal weakness worsens with sustained activity while sensation, pupils and reflexes remain preserved. Ocular findings need not follow one cranial nerve. Acetylcholine-receptor antibodies are most common; MuSK disease often has prominent bulbar, facial, neck and respiratory involvement. Seronegativity does not exclude MG. Repetitive nerve stimulation looks for a decrement, while single-fibre electromyography is sensitive but not disease-specific. The ice-pack test can support myasthenic ptosis; historical edrophonium testing carries cholinergic and cardiac risk and is not a casual bedside shortcut.
Differentiate Lambert-Eaton syndrome: proximal leg weakness, autonomic symptoms, reduced reflexes and post-exercise facilitation, with a malignancy association. Botulism has pupils and descending autonomic-bulbar paralysis; snake neurotoxicity is an Indian emergency mimic. Cholinergic excess causes muscarinic features and fasciculation in addition to weakness. Myasthenic crisis is defined by ventilatory or airway failure requiring support, not by one vital-capacity number. Neck weakness, cough, swallowing, secretions and trajectory matter, and normal oxygen saturation may coexist with dangerous hypoventilation.
Pyridostigmine improves symptoms but is not immunotherapy. Corticosteroids can initially worsen weakness. IVIG and plasma exchange are short-term rescue or bridge treatments; choice is contextual. Image the thymus in confirmed MG. Thymoma is a surgical indication when appropriate, while evidence for non-thymomatous thymectomy is strongest in selected 18-to-65-year-old, acetylcholine-receptor-antibody-positive generalised MG within five years of onset. Mycophenolate and methotrexate are incompatible with pregnancy planning; treatment changes should occur before conception under specialists. Magnesium, aminoglycosides, fluoroquinolones, macrolides, beta-blockers and neuromuscular blockers deserve caution, not rote refusal when another disease requires treatment.
Frequently Asked Questions
Can myasthenia gravis be present when antibody tests are negative?
Yes. Acetylcholine-receptor and MuSK antibodies identify many but not all patients. LRP4 or specialised cell-based assays may help selected cases, and neurophysiology can demonstrate impaired neuromuscular transmission. The final diagnosis still requires a compatible fluctuating weakness pattern and exclusion of mimics. A negative antibody result should trigger structured reassessment, not automatic dismissal or indefinite empirical immunosuppression.
Why is normal oxygen saturation not reassuring during possible myasthenic crisis?
Pulse oximetry can remain normal while respiratory muscles weaken and carbon dioxide rises. Upper-airway weakness and secretion retention can also cause sudden deterioration. Clinicians therefore repeat vital capacity or inspiratory pressure where available and assess speech, cough, swallowing, neck strength, breathing pattern and trajectory. Early critical-care and anaesthetic review permits planned support before hypoxaemia or arrest.
Does everyone with myasthenia gravis need thymectomy?
No. Thymoma generally requires surgical-oncology evaluation, but non-thymomatous thymectomy has its strongest trial evidence in a defined group with acetylcholine-receptor-antibody-positive generalised MG, age 18 to 65 and relatively recent disease. Evidence is less certain outside that population. Surgery is elective after stabilisation and should follow neurology and experienced thoracic-surgical review.
Which myasthenia treatments require special planning before pregnancy?
Mycophenolate and methotrexate are teratogenic and require specialist-led withdrawal and replacement before conception; other immunotherapies also need individual review. Abruptly stopping effective treatment can precipitate severe weakness. Pyridostigmine and selected immune treatments may be used under supervision. Preconception planning should involve neurology and high-risk obstetrics, with neonatal services alerted to possible transient neonatal myasthenia.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic